Home > Insider Trading > Filing (0001209191-20-011160)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651311	Merus N.v.	MRUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1790353	John Kruif De	C/O Merus N.v. Yalelaan 62 Utrecht P7 3584 CM	Svp & Chief Technology Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-02-18	2,222	$0.00	12,917	No	4	M	Direct
Common Shares	Disposition	2020-02-18	1,268	$18.98	11,649	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Share Option (right to buy)	Disposition	2020-02-18	2,222	$0.00	2,222	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-09-04	No	4	M	Direct

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Exercise price is denominated in Euros at 1.93.
Amount represents the weighted average price of shares sold, which ranged from $18.50 to $19.21. Details of individual transactions are available upon request.
These options are fully vested.
Number of derivative securities beneficially owned following the reported transaction is in reference to the number of options that remain outstanding of those originally granted on September 4, 2012.